Hantz Financial Services Inc. Buys 18,271 Shares of Colgate-Palmolive Company $CL

Hantz Financial Services Inc. grew its stake in Colgate-Palmolive Company (NYSE:CL) by 24.6% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 92,642 shares of the company’s stock after acquiring an additional 18,271 shares during the period. Hantz Financial Services Inc.’s holdings in Colgate-Palmolive were worth $7,321,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors also recently modified their holdings of the stock. HighPoint Advisor Group LLC raised its stake in shares of Colgate-Palmolive by 0.7% in the fourth quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock worth $1,255,000 after acquiring an additional 109 shares during the last quarter. Sunpointe LLC raised its stake in shares of Colgate-Palmolive by 4.0% in the fourth quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock worth $241,000 after acquiring an additional 117 shares during the last quarter. Capital Advisors Inc. OK raised its stake in shares of Colgate-Palmolive by 1.4% in the fourth quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock worth $758,000 after acquiring an additional 129 shares during the last quarter. Stratos Wealth Advisors LLC raised its stake in shares of Colgate-Palmolive by 4.5% in the third quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock worth $241,000 after acquiring an additional 130 shares during the last quarter. Finally, Eads & Heald Wealth Management raised its stake in shares of Colgate-Palmolive by 0.6% in the fourth quarter. Eads & Heald Wealth Management now owns 20,744 shares of the company’s stock worth $1,639,000 after acquiring an additional 132 shares during the last quarter. 80.41% of the stock is owned by institutional investors.

Colgate-Palmolive Trading Up 0.1%

CL opened at $90.66 on Tuesday. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33. The company has a debt-to-equity ratio of 16.33, a current ratio of 1.02 and a quick ratio of 0.67. The company has a market cap of $72.74 billion, a price-to-earnings ratio of 35.28, a price-to-earnings-growth ratio of 4.71 and a beta of 0.31. The firm has a 50 day simple moving average of $86.16 and a 200 day simple moving average of $85.32.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 EPS for the quarter, beating the consensus estimate of $0.94 by $0.03. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The firm had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.22 billion. During the same quarter in the prior year, the firm earned $0.91 earnings per share. The business’s quarterly revenue was up 8.4% on a year-over-year basis. On average, sell-side analysts anticipate that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, May 15th. Shareholders of record on Monday, April 20th were paid a $0.53 dividend. The ex-dividend date of this dividend was Monday, April 20th. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. This represents a $2.12 annualized dividend and a yield of 2.3%. Colgate-Palmolive’s payout ratio is currently 82.49%.

Analysts Set New Price Targets

A number of brokerages have weighed in on CL. JPMorgan Chase & Co. boosted their target price on shares of Colgate-Palmolive from $95.00 to $96.00 and gave the stock an “overweight” rating in a research note on Monday, May 4th. Barclays boosted their price target on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the stock an “equal weight” rating in a research note on Tuesday, May 5th. Morgan Stanley reissued an “overweight” rating on shares of Colgate-Palmolive in a research note on Monday, May 4th. UBS Group boosted their price target on shares of Colgate-Palmolive from $98.00 to $100.00 and gave the stock a “buy” rating in a research note on Monday, May 4th. Finally, Citigroup boosted their price target on shares of Colgate-Palmolive from $95.00 to $105.00 and gave the stock a “buy” rating in a research note on Monday, February 2nd. Twelve equities research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $95.88.

About Colgate-Palmolive

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.